Bailard’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,000
| Closed | -$344K | – | 812 |
|
|
2021
Q3 | $344K | Hold |
2,000
| – | – | 0.01% | 490 |
|
|
2021
Q2 | $251K | Sell |
2,000
-900
| -31% | -$113K | 0.01% | 607 |
|
|
2021
Q1 | $393K | Hold |
2,900
| – | – | 0.01% | 444 |
|
|
2020
Q4 | $371K | Sell |
2,900
-3,100
| -52% | -$397K | 0.02% | 392 |
|
|
2020
Q3 | $675K | Sell |
6,000
-1,000
| -14% | -$113K | 0.04% | 245 |
|
|
2020
Q2 | $667K | Hold |
7,000
| – | – | 0.04% | 232 |
|
|
2020
Q1 | $629K | Sell |
7,000
-1,000
| -13% | -$89.9K | 0.04% | 205 |
|
|
2019
Q4 | $424K | Sell |
8,000
-5,000
| -38% | -$265K | 0.02% | 333 |
|
|
2019
Q3 | $514K | Hold |
13,000
| – | – | 0.03% | 264 |
|
|
2019
Q2 | $534K | Buy |
13,000
+2,600
| +25% | +$107K | 0.03% | 274 |
|
|
2019
Q1 | $484K | Hold |
10,400
| – | – | 0.03% | 302 |
|
|
2018
Q4 | $453K | Sell |
10,400
-2,800
| -21% | -$122K | 0.03% | 321 |
|
|
2018
Q3 | $755K | Sell |
13,200
-300
| -2% | -$17.2K | 0.04% | 248 |
|
|
2018
Q2 | $655K | Buy |
13,500
+3,000
| +29% | +$146K | 0.04% | 284 |
|
|
2018
Q1 | $411K | Buy |
10,500
+2,500
| +31% | +$97.9K | 0.03% | 370 |
|
|
2017
Q4 | $340K | Buy |
+8,000
| New | +$340K | 0.02% | 358 |
|